| 000 | 01818 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516023937.0 | ||
| 264 | 0 | _c20110713 | |
| 008 | 201107s 0 0 eng d | ||
| 022 | _a1528-0020 | ||
| 024 | 7 |
_a10.1182/blood-2010-10-312082 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSlatter, Mary A | |
| 245 | 0 | 0 |
_aTreosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience. _h[electronic resource] |
| 260 |
_bBlood _cApr 2011 |
||
| 300 |
_a4367-75 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xadverse effects |
| 650 | 0 | 4 |
_aBusulfan _xadverse effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aChimerism |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aGraft vs Host Disease _xepidemiology |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Deficiency Syndromes _xsurgery |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aTransplantation Conditioning _xmethods |
| 650 | 0 | 4 | _aUnited Kingdom |
| 700 | 1 | _aRao, Kanchan | |
| 700 | 1 | _aAmrolia, Persis | |
| 700 | 1 | _aFlood, Terry | |
| 700 | 1 | _aAbinun, Mario | |
| 700 | 1 | _aHambleton, Sophie | |
| 700 | 1 | _aNademi, Zohreh | |
| 700 | 1 | _aGoulden, Nick | |
| 700 | 1 | _aDavies, Graham | |
| 700 | 1 | _aQasim, Waseem | |
| 700 | 1 | _aGaspar, Hubert B | |
| 700 | 1 | _aCant, Andrew | |
| 700 | 1 | _aGennery, Andrew R | |
| 700 | 1 | _aVeys, Paul | |
| 773 | 0 |
_tBlood _gvol. 117 _gno. 16 _gp. 4367-75 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2010-10-312082 _zAvailable from publisher's website |
| 999 |
_c20602600 _d20602600 |
||